Nichols William Garrett 4
4 · Candel Therapeutics, Inc. · Filed Jul 2, 2025
Insider Transaction Report
Form 4
Nichols William Garrett
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2025-06-30$1.29/sh+781$1,007→ 53,274 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-06-30−781→ 30,314 totalExercise: $1.29Exp: 2033-04-28→ Common Stock (781 underlying) - Sale
Common Stock
2025-06-30$5.04/sh−781$3,936→ 52,493 total
Footnotes (2)
- [F1]This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 11/22/2024.
- [F2]This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following April 28, 2023, subject to the Reporting Person's continued service on each vesting date.